Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIRETROVIRAL THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2149 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. Skiest, DJ
      Focal neurological disease in patients with acquired immunodeficiency syndrome

      CLINICAL INFECTIOUS DISEASES
    3. Vietri, NJ; Skidmore, PJ; Dooley, DP
      Esophageal ulceration due to cytomegalovirus infection in a patient with acute retroviral syndrome

      CLINICAL INFECTIOUS DISEASES
    4. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    5. Devereux, HL; Burke, A; Lee, CA; Johnson, MA
      In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution

      JOURNAL OF MEDICAL VIROLOGY
    6. Martin-Serrano, J; Li, K; Bieniasz, PD
      Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes

      JOURNAL OF VIROLOGY
    7. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
      Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Mahajan, AP; Tashima, KT; Bausserman, LL; Flynn, MM; Carpenter, CCJ
      Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Deeks, SG; Barditch-Crovo, P; Collier, A; Smith, A; Miller, M; McGowan, M; Coakley, DF
      Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Asch, SM; Gifford, AL; Bozzette, SA; Turner, B; Mathews, WC; Kuromiya, K; Cunningham, W; Andersen, R; Shapiro, M; Rastegar, A; McCutchan, JA
      Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Hsu, LC; Vittinghoff, E; Katz, MH; Schwarcz, SK
      Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Tyndall, MW; Craib, KJP; Currie, S; Li, K; O'Shaughnessy, MV; Schechter, MT
      Impact of HIV infection on mortality in a cohort of injection drug users

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Cohn, SE; Berk, ML; Berry, SH; Duan, NH; Frankel, MR; Klein, JD; McKinney, MM; Rastegar, A; Smith, S; Shapiro, MF; Bozzette, SA
      The care of HIV-infected adults in rural areas of the United States

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Moyle, G; Baldwin, C; Mandalia, S; Comitis, S; Burn, P; Gazzard, B
      Changes in metabolic parameters and body shape after replacement of protease inhibitor with efavirenz in virologically controlled HIV-1-positive persons: Single-arm observational cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Ghani, AC; de Wolf, F; Ferguson, NM; Donnelly, CA; Coutinho, R; Miedema, F; Goudsmit, J; Anderson, RM
      Surrogate markers for disease progression in treated HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Zinkernagel, C; Taffe, P; Rickenbach, M; Amiet, R; Ledergerber, B; Volkart, AC; Rauchfleisch, U; Kiss, A; Werder, V; Vernazza, P; Battegay, M
      Importance of mental health assessment in HIV-infected outpatients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Beinker, NK; Mayers, DL; Lange, CG; Valdez, H; Sitkins, J; Lemonnier, L; Chowdhry, TK; Lederman, MM
      Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Wilson, IB; Tchetgen, E; Spiegelman, D
      Patterns of adherence with antiretroviral medications: An examination of between-medication differences

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Sackoff, JE; Shin, SS
      Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Laufer, FN
      Cost-effectiveness of syringe exchange as an HIV prevention strategy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Buchacz, K; van der Straten, A; Saul, J; Shiboski, SC; Gomez, CA; Padian, N
      Sociodemographic, behavioral, and clinical correlates of inconsistent condom use in HIV-serodiscordant heterosexual couples

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Stone, VE; Hogan, JW; Schuman, P; Rompalo, AM; Howard, AA; Korkontzelou, C; Smith, DK
      Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Delbeke, E
      HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Lafeuillade, A; Halfon, P; Chadapaud, S; Hittinger, G; Khiri, H; Poggi, C
      Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Rompalo, AM; Shah, N; Mayer, K; Schuman, T; Klein, RS; Smith, DK; Vlahov, D
      Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV epidemiology research study: On-site versus referral care

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Altice, FL; Mostashari, F; Friedland, GH
      Trust and the acceptance of and adherence to antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Orloff, SL; Bulterys, M; Vink, P; Nesheim, S; Abrams, EJ; Schoenbaum, E; Palumbo, P; Steketee, RW; Simonds, RJ
      Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US Cities, 1994-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Fleishman, JA; Hellinger, FJ
      Trends in HIV-related inpatient admissions from 1993 to 1997: A seven-state study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Miller, MD; Margot, NA; Lamy, PD; Fuller, MD; Anton, KE; Mulato, AS; Cherrington, JM
      Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Roberts, DE; Ribeiro, RM
      Comparison of different treatment regimens for the emergence of new resistance under therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
      Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Le Moing, V; Chene, G; Carrieri, MP; Besnier, JM; Masquelier, B; Salamon, R; Bazin, C; Moatti, JP; Raffi, F; Leport, C
      Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Leng, QB; Borkow, G; Weisman, Z; Stein, M; Kalinkovich, A; Bentwich, Z
      Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    41. Duong, M; Petit, JM; Piroth, L; Grappin, M; Buisson, M; Chavanet, P; Hillon, S; Portier, H
      Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    42. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
      Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    43. Bisset, LR; Cone, RW; Fischer, M; Battegay, M; Vernazza, PL; Dubs, RW; Weber, R; Grob, PJ; Opravil, M
      Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    44. Wilson, TE; Minkoff, H
      Condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    45. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    46. Gebo, KA; Diener-West, M; Moore, RD
      Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    47. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    48. Brambilla, AM; Castagna, A; Nocita, B; Hasson, H; Boeri, E; Veglia, F; Lazzarin, A
      Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    49. Funk, GA; Fischer, M; Joos, B; Opravil, M; Gunthard, HF; Ledergerber, B; Bonhoeffer, S
      Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    50. Nelson, PW; Mittler, JE; Perelson, AS
      Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    51. Bangsberg, DR; Hecht, FM; Clague, H; Charlebois, ED; Ciccarone, D; Chesney, M; Moss, A
      Provider assessment of adherence to HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    52. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    53. Pezzotti, P; Pappagallo, M; Phillips, PN; Boros, S; Valdarchi, C; Sinicco, A; Zaccarelli, M; Rezza, G
      Response to highly active antiretroviral therapy according to duration of HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    54. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    55. Adje, C; Cheingsong, R; Roels, TH; Maurice, C; Djomand, G; Verbiest, W; Hertogs, K; Larder, B; Monga, B; Peeters, M; Eholie, S; Bissagene, E; Coulibaly, M; Respess, R; Wiktor, SZ; Chorba, T; Nkengasong, JN
      High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    56. Para, MF; Kalish, LA; Collier, AC; Pollard, RB; Kumar, PN; Mintz, L; Wallach, FR; Drew, WL
      Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    57. Kost, RG; Hurley, A; Zhang, LQ; Vesanen, M; Talal, A; Furlan, S; Caldwell, P; Johnson, J; Smiley, L; Ho, D; Markowitz, M
      Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    58. Talal, AH; Irwin, CE; Dieterich, DT; Yee, H; Zhang, LQ
      Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    59. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    60. Abgrall, S; Matheron, S; Le Moing, V; Dupont, C; Costagliola, D
      Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    61. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
      Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    62. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    63. Kleeberger, CA; Phair, JP; Strathdee, SA; Detels, R; Kingsley, L; Jacobson, LP
      Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    64. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    65. Miller, V
      Resistance to protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    66. Saves, M; Morlat, P; Chene, G; Peuchant, E; Pellegrin, I; Bonnet, F; Bernard, N; Lacoste, D; Salamon, R; Beylot, J
      Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

      CLINICAL IMMUNOLOGY
    67. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
      Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion

      CLINICAL IMMUNOLOGY
    68. de Martino, M; Chiarelli, F; Moriondo, M; Torello, M; Azzari, C; Galli, L
      Restored antioxidant capacity parallels the immunologic and virologic improvement in children with perinatal human immunodeficiency virus infection receiving highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    69. Montaner, LJ
      Structured treatment interruptions to control HIV-1 and limit drug exposure

      TRENDS IN IMMUNOLOGY
    70. Imami, N; Hardy, G; Gotch, F
      Development of immunotherapeutic strategies for HIV-1

      EXPERT OPINION ON BIOLOGICAL THERAPY
    71. Soni, N; Pozniak, A
      Continuing HIV therapy in the ICU

      CRITICAL CARE
    72. Gan, SK; Samaras, K; Carr, A; Chisholm, D
      Anti-retroviral therapy, insulin resistance and lipodystrophy

      DIABETES OBESITY & METABOLISM
    73. Sasadeusz, J
      Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones

      INTERNAL MEDICINE JOURNAL
    74. Gajdatsy, AD; Tay-Kearney, ML
      Microsporidial keratoconjunctivitis after HAART

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    75. Rossi, M; Flepp, M; Telenti, A; Schiffer, V; Egloff, N; Bucher, H; Vernazza, P; Bernasconi, E; Weber, R; Rickenbach, M; Furrer, H
      Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy

      SWISS MEDICAL WEEKLY
    76. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    77. Gahan, ME; Miller, F; Lewin, SR; Cherry, CL; Hoy, JF; Mijch, A; Rosenfeldt, F; Wesselingh, SL
      Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction

      JOURNAL OF CLINICAL VIROLOGY
    78. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
      Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?

      JOURNAL OF CLINICAL VIROLOGY
    79. Price, P; Mathiot, N; Krueger, R; Stone, S; Keane, NM; French, MA
      Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy

      JOURNAL OF CLINICAL VIROLOGY
    80. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    81. Zollner, B; Feucht, HH; Weitner, L; Adam, A; Schroter, M; Schafer, P; Laufs, R
      Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients

      JOURNAL OF CLINICAL VIROLOGY
    82. Alfano, M; Poli, G
      Cytokine and chemokine based control of HIV infection and replication

      CURRENT PHARMACEUTICAL DESIGN
    83. Kijak, GH; Avila, MM; Salomon, H
      Mother-to-child transmission of drug-resistant HIV

      DRUG RESISTANCE UPDATES
    84. Jungmann, EM; Mercey, D; DeRuiter, A; Edwards, S; Donoghue, S; Booth, T; Mohan, D; Lyall, H; Taylor, GP
      Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?

      SEXUALLY TRANSMITTED INFECTIONS
    85. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
      Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens

      SEXUALLY TRANSMITTED INFECTIONS
    86. Pao, D; Watson, C; Peters, B; Lucas, SB; Miller, RF
      Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors

      SEXUALLY TRANSMITTED INFECTIONS
    87. Brook, MG; Miller, RF
      HIV associated nephropathy: a treatable condition

      SEXUALLY TRANSMITTED INFECTIONS
    88. Pronyk, PM; Kim, J; Porter, JDH
      Editorial: Whose priorities? A response to the issue of antiretrovirals inAfrica

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    89. Rozenbaum, W; Katlama, C; Massip, P; Bentata, M; Zucman, D; Delfraissy, JF; Trepo, C; David, F; Lanier, ER; Vavro, C; Mamet, JP
      Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment

      ANTIVIRAL THERAPY
    90. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    91. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
      Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial

      ANTIVIRAL THERAPY
    92. Saracino, A; Di Stefano, M; Vimercati, A; Greco, P; Fiore, JR; Monno, L; Angarano, G; Pastore, G
      Cervicovaginal HIV-1 shedding in pregnant women near delivery

      ANTIVIRAL THERAPY
    93. Squires, KE
      An introduction to nucleoside and nucleotide analogues

      ANTIVIRAL THERAPY
    94. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    95. Miller, V
      Interpretation of resistance assay results

      ANTIVIRAL THERAPY
    96. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    97. Weber, T; Weber, F; Petry, H; Luke, W
      Immune response in progressive multifocal leukoencephalopathy: An overview

      JOURNAL OF NEUROVIROLOGY
    98. Du Pasquier, RA; Clark, KW; Smith, PS; Joseph, JT; Mazullo, JM; De Girolami, U; Letvin, NL; Koralnik, IJ
      JCV-specific cellular immune response correlates with a favorable clinicaloutcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    99. Antinori, A; Ammassari, A; Giancola, ML; Cingolani, A; Grisetti, S; Murri, R; Alba, L; Ciancio, B; Soldani, F; Larussa, D; Ippolito, G; De Luca, A
      Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era

      JOURNAL OF NEUROVIROLOGY
    100. Berger, JR; Chauhan, A; Galey, D; Nath, A
      Epidemiological evidence and molecular basis of interactions between HIV and JC virus

      JOURNAL OF NEUROVIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:19:23